PetVivo Receives Notice Of Allowance From U.S Patent And Trademark Office For Patent Entitled "Biocompatible Protein-Based Particles And Methods Thereof"
Portfolio Pulse from Benzinga Newsdesk
PetVivo has received a Notice of Allowance from the U.S Patent and Trademark Office for a patent titled 'Biocompatible Protein-Based Particles And Methods Thereof'.
August 17, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PetVivo's new patent allowance could potentially strengthen its intellectual property portfolio and provide a competitive edge in the market.
The allowance of a new patent typically strengthens a company's intellectual property portfolio, potentially providing a competitive advantage. This could positively impact PetVivo's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100